Cases & Deals

Celgene invests in Acceleron Pharma

Clients Celgene Corporation

Jones Day advised Celgene Corporation in connection with its purchase of Series C-1 Preferred Stock in a private placement by Acceleron Pharma, Inc., a biopharmaceutical company.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.